Home
Stoke Therapeutics STOK paid Ferox Strategies $40K for lobbying in Q1 2026 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $40,000
- Quarter
- Q1 2026
- Client
- Stoke Therapeutics
- Reported
- 26/04/17
Up 0.0% from last quarter
What else happened in Stoke Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Stoke Therapeutics's other lobbying reports
- Stoke Therapeutics
LobbyingStoke Therapeutics
LobbyingStoke Therapeutics
STOK
$40K
$40K
Reported 07/20
for Q2
- Stoke Therapeutics
LobbyingStoke Therapeutics
LobbyingStoke Therapeutics
STOK
$40K
$40K
Reported 01/20
for Q4 2025
- Stoke Therapeutics
LobbyingStoke Therapeutics
LobbyingStoke Therapeutics
STOK
$40K
$40K
Reported 25/10/20
for Q3 2025
- Stoke Therapeutics
LobbyingStoke Therapeutics
LobbyingStoke Therapeutics
STOK
$20K
$20K
Reported 25/07/18
for Q2 2025
- Stoke Therapeutics
LobbyingStoke Therapeutics
LobbyingStoke Therapeutics
STOK
$30K
$30K
Reported 23/01/19
for Q4 2022